Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Emmanuel Delamarche's Biography



Emmanuel Delamarche, Senior Manager, Spiden AG

Dr. Delamarche is currently a Senior Manager at Spiden AG, a Swiss company developing medical technologies. Prior to this, Dr. Delamarche was leading activities on Precision Diagnostics at IBM Research - Zurich where his main projects dealt with the development of portable and precise diagnostic devices and of a non-contact scanning microfluidic probe for analyzing biological interfaces. He is also a Lecturer at ETH Zurich and a contributor to scientific panels for governmental agencies and research institutions. He published over 200 papers and proceedings, and is co-inventor on more than 70 patent families. He has received numerous awards from IBM, was named “Master Inventor” by IBM, and received the Werner prize of the Swiss Chemical Society in 2006 and Langmuir Lecture Award in 2020 from the American Chemical Society. Dr. Delamarche studied chemistry and received a degree in supramolecular chemistry in 1992 from the University Paul Sabatier of Toulouse in France and his Ph.D. in biochemistry in 1995 from the University of Zurich.

Emmanuel Delamarche Image

Agenda is not currently available
Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonMicrofluidics to Address Pandemics - SARS-CoV-2 and BeyondMicrofluidics to Address Pandemics - SARS-CoV-2 and Beyond in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com